ImmunityBio, Inc. IBRX

Sick of the slow SP bleed

Let's hope for a good quarterly call

Earnings around 11-2 so this week should be A dull week

It's infuriating how the FDA protected Keytruda and Merck and still are slow balling ImmunityBio

The FDA fucked ImmunityBio with the bladder approvals to protect Keytruda and Merck sales..... it's infuriating

Can someone explain how Merck got Keytruda approved for so many cancers..

Thanks

Anktiva struggles to just get approved for all of bladder cancers. Which are really all the same.

https://www.facebook.com/share/v/1KGcqwr4fi/?mibextid=wwXIfr

The biggest issue is the FDA slow balls small cutting edge companies so big pharma can catch up.

Sickening as the population suffers. The FDA and Big Pharma are all about themselves and money.

John Jones good post

Well down 22% in two weeks with good news makes zero sense. Well it does. Only people that have IBRX or are following know the news. I got zero coverage by the $$$$ driven POS MSM like CNBC or FoxB

Crave Morehead go fuck yourself you are a gross PIG 🐖🐖🐖🐖🐖🖕🖕🖕🖕🖕🖕